Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Knight Therapeutics Inc
(OP:
KHTRF
)
4.230
+0.120 (+2.92%)
Streaming Delayed Price
Updated: 3:17 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,421
Open
4.230
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
4.110
Today's Range
4.230 - 4.230
52wk Range
3.201 - 4.410
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is Ardelyx is A Buy After Slip in Early 2022
November 21, 2022
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them
Via
MarketBeat
Exposures
Product Safety
Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America
May 24, 2022
Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF)
Via
Benzinga
Performance
YTD
+9.13%
+9.13%
1 Month
+2.92%
+2.92%
3 Month
N/A
N/A
6 Month
+4.44%
+4.44%
1 Year
+24.05%
+24.05%
More News
Read More
Puma Biotech's Nerlynx Wins Canadian Approval In HER2-Positive Metastatic Breast Cancer
July 06, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.